Forum Financial Management LP Makes New $401,000 Investment in Hims & Hers Health, Inc. $HIMS

Forum Financial Management LP bought a new stake in shares of Hims & Hers Health, Inc. (NYSE:HIMS) in the 2nd quarter, HoldingsChannel reports. The fund bought 8,037 shares of the company’s stock, valued at approximately $401,000.

Other hedge funds also recently made changes to their positions in the company. Geneos Wealth Management Inc. bought a new position in Hims & Hers Health during the first quarter valued at about $30,000. BI Asset Management Fondsmaeglerselskab A S purchased a new position in Hims & Hers Health in the first quarter valued at about $41,000. Larson Financial Group LLC grew its position in shares of Hims & Hers Health by 47.7% during the 1st quarter. Larson Financial Group LLC now owns 1,419 shares of the company’s stock valued at $42,000 after acquiring an additional 458 shares during the period. Webster Bank N. A. increased its stake in shares of Hims & Hers Health by 229.1% during the 2nd quarter. Webster Bank N. A. now owns 905 shares of the company’s stock worth $45,000 after purchasing an additional 630 shares during the last quarter. Finally, Tsfg LLC bought a new stake in shares of Hims & Hers Health in the 1st quarter worth approximately $46,000. 63.52% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on the company. Zacks Research downgraded Hims & Hers Health from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, August 19th. Truist Financial lowered their price objective on Hims & Hers Health from $48.00 to $37.00 and set a “hold” rating on the stock in a research note on Monday, August 18th. Canaccord Genuity Group reiterated a “buy” rating and set a $68.00 target price on shares of Hims & Hers Health in a research report on Friday, September 12th. Wall Street Zen lowered shares of Hims & Hers Health from a “buy” rating to a “hold” rating in a research report on Monday, July 28th. Finally, Weiss Ratings reiterated a “hold (c+)” rating on shares of Hims & Hers Health in a research note on Tuesday, October 14th. Two research analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Reduce” and an average price target of $38.92.

Hims & Hers Health Trading Up 0.8%

Shares of Hims & Hers Health stock opened at $48.86 on Friday. The company’s 50-day moving average price is $51.14 and its 200-day moving average price is $49.66. The company has a current ratio of 4.98, a quick ratio of 4.46 and a debt-to-equity ratio of 1.72. Hims & Hers Health, Inc. has a 12-month low of $18.33 and a 12-month high of $72.98. The company has a market cap of $11.04 billion, a price-to-earnings ratio of 61.07, a PEG ratio of 3.38 and a beta of 2.25.

Hims & Hers Health (NYSE:HIMS) last posted its earnings results on Monday, August 4th. The company reported $0.17 earnings per share for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.01). Hims & Hers Health had a return on equity of 26.26% and a net margin of 9.63%.The firm had revenue of $544.83 million for the quarter, compared to the consensus estimate of $550.06 million. During the same period last year, the company posted $0.06 EPS. The business’s revenue was up 72.6% on a year-over-year basis. Hims & Hers Health has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. On average, equities analysts expect that Hims & Hers Health, Inc. will post 0.29 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Hims & Hers Health news, insider Soleil Boughton sold 2,637 shares of the firm’s stock in a transaction dated Monday, October 13th. The stock was sold at an average price of $54.38, for a total value of $143,400.06. Following the sale, the insider owned 161,130 shares of the company’s stock, valued at $8,762,249.40. This trade represents a 1.61% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Patrick Harrison Carroll sold 10,021 shares of Hims & Hers Health stock in a transaction dated Wednesday, September 17th. The shares were sold at an average price of $50.50, for a total value of $506,060.50. Following the sale, the insider owned 169,940 shares of the company’s stock, valued at approximately $8,581,970. This trade represents a 5.57% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 1,432,206 shares of company stock worth $74,248,448. 13.71% of the stock is currently owned by corporate insiders.

Hims & Hers Health Company Profile

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.